Header Logo

Connection

Stephen Eeden to Aged

This is a "connection" page, showing publications Stephen Eeden has written about Aged.
Connection Strength

2.884
  1. The Kaiser Permanente Research Bank Cancer Cohort: a collaborative resource to improve cancer care and survivorship. BMC Cancer. 2022 Feb 25; 22(1):209.
    View in: PubMed
    Score: 0.048
  2. Multicenter Comparison of 17-Gene Genomic Prostate Score as a Predictor of Outcomes in African American and Caucasian American Men with Clinically Localized Prostate Cancer. J Urol. 2021 Apr; 205(4):1047-1054.
    View in: PubMed
    Score: 0.044
  3. Long-term follow-up of a racially and ethnically diverse population of men with localized prostate cancer who did not undergo initial active treatment. Cancer Med. 2020 11; 9(22):8530-8539.
    View in: PubMed
    Score: 0.043
  4. Interpersonal Trauma as a Marker of Risk for Urinary Tract Dysfunction in Midlife and Older Women. Obstet Gynecol. 2020 01; 135(1):106-112.
    View in: PubMed
    Score: 0.041
  5. Selecting Active Surveillance: Decision Making Factors for Men with a Low-Risk Prostate Cancer. Med Decis Making. 2019 11; 39(8):962-974.
    View in: PubMed
    Score: 0.041
  6. Patients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancer. Diabetes Care. 2010 Jan; 33(1):55-60.
    View in: PubMed
    Score: 0.041
  7. Statins as a free pass: Body mass index and other cardiovascular risk factors among lipid-lowering medication users and nonusers in the California Men's Health Study. Prev Med. 2019 12; 129:105822.
    View in: PubMed
    Score: 0.040
  8. A genome-wide association study of prostate cancer in Latinos. Int J Cancer. 2020 04 01; 146(7):1819-1826.
    View in: PubMed
    Score: 0.040
  9. Genetic variation in the SIM1 locus is associated with erectile dysfunction. Proc Natl Acad Sci U S A. 2018 10 23; 115(43):11018-11023.
    View in: PubMed
    Score: 0.038
  10. The Use of 5-Alpha Reductase Inhibitors to Manage Benign Prostatic Hyperplasia and the Risk of All-cause Mortality. Urology. 2018 Sep; 119:70-78.
    View in: PubMed
    Score: 0.037
  11. High-resolution mapping of traffic related air pollution with Google street view cars and incidence of cardiovascular events within neighborhoods in Oakland, CA. Environ Health. 2018 05 15; 17(1):38.
    View in: PubMed
    Score: 0.037
  12. Quality of life among men with low-risk prostate cancer during the first year following diagnosis: the PREPARE prospective cohort study. Transl Behav Med. 2018 03 01; 8(2):156-165.
    View in: PubMed
    Score: 0.036
  13. The Relationship Between Nonsteroidal Anti-inflammatory Drug Use and Age-related Macular Degeneration. Am J Ophthalmol. 2018 04; 188:111-122.
    View in: PubMed
    Score: 0.036
  14. Identification of fluorescence in situ hybridization assay markers for prediction of disease progression in prostate cancer patients on active surveillance. BMC Cancer. 2018 01 02; 18(1):2.
    View in: PubMed
    Score: 0.036
  15. A Biopsy-based 17-gene Genomic Prostate Score as a Predictor of Metastases and Prostate Cancer Death in Surgically Treated Men with Clinically Localized Disease. Eur Urol. 2018 01; 73(1):129-138.
    View in: PubMed
    Score: 0.035
  16. Cardiovascular disease risk and androgen deprivation therapy in patients with localised prostate cancer: a prospective cohort study. Br J Cancer. 2017 Oct 10; 117(8):1233-1240.
    View in: PubMed
    Score: 0.035
  17. Decision-making processes among men with low-risk prostate cancer: A survey study. Psychooncology. 2018 01; 27(1):325-332.
    View in: PubMed
    Score: 0.035
  18. Mortality and Androgen Deprivation Therapy as Salvage Treatment for Biochemical Recurrence after Primary Therapy for Clinically Localized Prostate Cancer. J Urol. 2017 06; 197(6):1448-1454.
    View in: PubMed
    Score: 0.033
  19. Lack of replication of thirteen single-nucleotide polymorphisms implicated in Parkinson's disease: a large-scale international study. Lancet Neurol. 2006 Nov; 5(11):917-23.
    View in: PubMed
    Score: 0.033
  20. 5-Alpha Reductase Inhibitors and the Risk of Prostate Cancer Mortality in Men Treated for Benign Prostatic Hyperplasia. Mayo Clin Proc. 2016 Dec; 91(12):1717-1726.
    View in: PubMed
    Score: 0.033
  21. Use of sildenafil or other phosphodiesterase inhibitors and risk of melanoma. Br J Cancer. 2016 09 27; 115(7):895-900.
    View in: PubMed
    Score: 0.033
  22. California Men's Health Study (CMHS): a multiethnic cohort in a managed care setting. BMC Public Health. 2006 Jun 30; 6:172.
    View in: PubMed
    Score: 0.032
  23. Treatment Preferences for Active Surveillance versus Active Treatment among Men with Low-Risk Prostate Cancer. Cancer Epidemiol Biomarkers Prev. 2016 08; 25(8):1240-50.
    View in: PubMed
    Score: 0.032
  24. Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer. World J Urol. 2016 Dec; 34(12):1611-1619.
    View in: PubMed
    Score: 0.032
  25. Sociodemographic and Clinical Predictors of Switching to Active Treatment among a Large, Ethnically Diverse Cohort of Men with Low Risk Prostate Cancer on Observational Management. J Urol. 2016 Sep; 196(3):734-40.
    View in: PubMed
    Score: 0.032
  26. Predictors of impact of vaginal symptoms in postmenopausal women. Menopause. 2016 Jan; 23(1):40-6.
    View in: PubMed
    Score: 0.031
  27. Bridging the gap: determinants of undiagnosed or untreated urinary incontinence in women. Am J Obstet Gynecol. 2016 Feb; 214(2):266.e1-266.e9.
    View in: PubMed
    Score: 0.031
  28. Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California. Sleep. 2015 Jul 01; 38(7):1009-15.
    View in: PubMed
    Score: 0.030
  29. Prediagnostic Sex Steroid Hormones in Relation to Male Breast Cancer Risk. J Clin Oncol. 2015 Jun 20; 33(18):2041-50.
    View in: PubMed
    Score: 0.030
  30. Imputation of the rare HOXB13 G84E mutation and cancer risk in a large population-based cohort. PLoS Genet. 2015 Jan; 11(1):e1004930.
    View in: PubMed
    Score: 0.029
  31. The burden of nocturia among middle-aged and older women. Obstet Gynecol. 2015 Jan; 125(1):35-43.
    View in: PubMed
    Score: 0.029
  32. Risk of diabetes among patients receiving primary androgen deprivation therapy for clinically localized prostate cancer. J Urol. 2015 Jun; 193(6):1956-62.
    View in: PubMed
    Score: 0.029
  33. Association between cannabis use and the risk of bladder cancer: results from the California Men's Health Study. Urology. 2015 Feb; 85(2):388-92.
    View in: PubMed
    Score: 0.029
  34. The impact of multimorbidity on sexual function in middle-aged and older women: beyond the single disease perspective. J Sex Med. 2014 Nov; 11(11):2744-55.
    View in: PubMed
    Score: 0.028
  35. Progression and treatment of incident lower urinary tract symptoms (LUTS) among men in the California Men's Health Study. BJU Int. 2015 Jan; 115(1):127-33.
    View in: PubMed
    Score: 0.028
  36. Prostate cancer incidence and prostate-specific antigen testing among HIV-positive and HIV-negative men. J Acquir Immune Defic Syndr. 2014 Aug 15; 66(5):495-502.
    View in: PubMed
    Score: 0.028
  37. The risk for malignant primary adult-onset glioma in a large, multiethnic, managed-care cohort: cigarette smoking and other lifestyle behaviors. J Neurooncol. 2004 May; 68(1):57-69.
    View in: PubMed
    Score: 0.028
  38. Effectiveness of primary androgen-deprivation therapy for clinically localized prostate cancer. J Clin Oncol. 2014 May 01; 32(13):1324-30.
    View in: PubMed
    Score: 0.028
  39. Childbirth and female sexual function later in life. Obstet Gynecol. 2013 Nov; 122(5):988-97.
    View in: PubMed
    Score: 0.027
  40. Cohort study of insulin glargine and risk of breast, prostate, and colorectal cancer among patients with diabetes. Diabetes Care. 2013 Dec; 36(12):3953-60.
    View in: PubMed
    Score: 0.027
  41. Glycemic control and urinary incontinence in women with diabetes mellitus. J Womens Health (Larchmt). 2013 Dec; 22(12):1049-55.
    View in: PubMed
    Score: 0.027
  42. Family history of diabetes and pancreatic cancer as risk factors for pancreatic cancer: the PACIFIC study. Cancer Epidemiol Biomarkers Prev. 2013 Oct; 22(10):1913-7.
    View in: PubMed
    Score: 0.027
  43. Association of body mass index and prostate cancer mortality. Obes Res Clin Pract. 2014 Jul-Aug; 8(4):e374-81.
    View in: PubMed
    Score: 0.026
  44. Immunohistochemical expression of ERG in the molecular epidemiology of fatal prostate cancer study. Prostate. 2013 Sep; 73(13):1371-7.
    View in: PubMed
    Score: 0.026
  45. Impact of type 2 diabetes on lower urinary tract symptoms in men: a cohort study. BMC Urol. 2013 Feb 20; 13:12.
    View in: PubMed
    Score: 0.026
  46. A prognostic assay to identify patients at high risk of mortality despite small, node-negative lung tumors. JAMA. 2012 Oct 24; 308(16):1629-31.
    View in: PubMed
    Score: 0.025
  47. Fecal incontinence decreases sexual quality of life, but does not prevent sexual activity in women. Dis Colon Rectum. 2012 Oct; 55(10):1059-65.
    View in: PubMed
    Score: 0.025
  48. Diabetes mellitus and sexual function in middle-aged and older women. Obstet Gynecol. 2012 Aug; 120(2 Pt 1):331-40.
    View in: PubMed
    Score: 0.025
  49. Clinical effectiveness of pneumococcal polysaccharide vaccine in men: California Men's Health Study. Vaccine. 2012 Aug 17; 30(38):5625-30.
    View in: PubMed
    Score: 0.025
  50. Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer. Urology. 2012 May; 79(5):1034-41.
    View in: PubMed
    Score: 0.024
  51. A high-density genome-wide association screen of sporadic ALS in US veterans. PLoS One. 2012; 7(3):e32768.
    View in: PubMed
    Score: 0.024
  52. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012 Mar 03; 379(9818):823-32.
    View in: PubMed
    Score: 0.024
  53. Valvular heart disease in patients exposed to pergolide: insights from the clinical presentation. Pharmacoepidemiol Drug Saf. 2012 Mar; 21(3):276-80.
    View in: PubMed
    Score: 0.024
  54. Preventive care and health behaviors among overweight/obese men in HMOs. Am J Manag Care. 2012 Jan; 18(1):25-32.
    View in: PubMed
    Score: 0.024
  55. A comparison of lifestyle and behavioral cardiovascular disease risk factors between Asian Indian and White non-Hispanic men. Ethn Dis. 2012; 22(2):168-74.
    View in: PubMed
    Score: 0.024
  56. Evaluating racial/ethnic disparities in lower urinary tract symptoms in men. J Urol. 2012 Jan; 187(1):185-9.
    View in: PubMed
    Score: 0.024
  57. Population-based study of erectile dysfunction and polypharmacy. BJU Int. 2012 Jul; 110(2):254-9.
    View in: PubMed
    Score: 0.024
  58. Contribution of common medications to lower urinary tract symptoms in men. Arch Intern Med. 2011 Oct 10; 171(18):1680-2.
    View in: PubMed
    Score: 0.023
  59. Urinary incontinence self-report questions: reproducibility and agreement with bladder diary. Int Urogynecol J. 2011 Dec; 22(12):1565-71.
    View in: PubMed
    Score: 0.023
  60. Association of DRD2 and DRD3 polymorphisms with Parkinson's disease in a multiethnic consortium. J Neurol Sci. 2011 Aug 15; 307(1-2):22-9.
    View in: PubMed
    Score: 0.023
  61. Regular nonsteroidal anti-inflammatory drug use and erectile dysfunction. J Urol. 2011 Apr; 185(4):1388-93.
    View in: PubMed
    Score: 0.022
  62. Cross-cancer evaluation of polygenic risk scores for 16 cancer types in two large cohorts. Nat Commun. 2021 02 12; 12(1):970.
    View in: PubMed
    Score: 0.022
  63. Coffee, ADORA2A, and CYP1A2: the caffeine connection in Parkinson's disease. Eur J Neurol. 2011 May; 18(5):756-65.
    View in: PubMed
    Score: 0.022
  64. Complementary and alternative medicine use among newly diagnosed prostate cancer patients. Support Care Cancer. 2012 Jan; 20(1):65-73.
    View in: PubMed
    Score: 0.022
  65. Familial aggregation of Parkinson's disease in a multiethnic community-based case-control study. Mov Disord. 2010 Nov 15; 25(15):2587-94.
    View in: PubMed
    Score: 0.022
  66. Comorbid cancer in Parkinson's disease. Mov Disord. 2010 Sep 15; 25(12):1809-17.
    View in: PubMed
    Score: 0.022
  67. Pan-cancer study detects genetic risk variants and shared genetic basis in two large cohorts. Nat Commun. 2020 09 04; 11(1):4423.
    View in: PubMed
    Score: 0.022
  68. Lactation and maternal risk of type 2 diabetes: a population-based study. Am J Med. 2010 Sep; 123(9):863.e1-6.
    View in: PubMed
    Score: 0.022
  69. Incidence of and risk factors for change in urinary incontinence status in a prospective cohort of middle-aged and older women: the reproductive risk of incontinence study in Kaiser. J Urol. 2010 Oct; 184(4):1394-401.
    View in: PubMed
    Score: 0.022
  70. Women with diabetes: understanding urinary incontinence and help seeking behavior. J Urol. 2010 Oct; 184(4):1402-7.
    View in: PubMed
    Score: 0.022
  71. Associations Between Prediagnostic Concentrations of Circulating Sex Steroid Hormones and Liver Cancer Among Postmenopausal Women. Hepatology. 2020 08; 72(2):535-547.
    View in: PubMed
    Score: 0.022
  72. Patient recruitment methods to evaluate treatment decision making for localized prostate cancer. Am J Clin Oncol. 2010 Aug; 33(4):381-6.
    View in: PubMed
    Score: 0.021
  73. Unanticipated and underappreciated outcomes during management of local stage prostate cancer: a prospective survey. J Urol. 2010 Jul; 184(1):120-5.
    View in: PubMed
    Score: 0.021
  74. Autoimmune diseases prior to the diagnosis of multiple sclerosis: a population-based case-control study. Mult Scler. 2010 Jul; 16(7):855-61.
    View in: PubMed
    Score: 0.021
  75. Pneumococcal vaccination and risk of acute myocardial infarction and stroke in men. JAMA. 2010 May 05; 303(17):1699-706.
    View in: PubMed
    Score: 0.021
  76. Reliability and validity of two self-administered questionnaires for screening restless legs syndrome in population-based studies. Sleep Med. 2010 Feb; 11(2):154-60.
    View in: PubMed
    Score: 0.021
  77. Red wine consumption and risk of prostate cancer: the California men's health study. Int J Cancer. 2010 Jan 01; 126(1):171-9.
    View in: PubMed
    Score: 0.021
  78. Clinical features in early Parkinson disease and survival. Arch Neurol. 2009 Nov; 66(11):1353-8.
    View in: PubMed
    Score: 0.020
  79. Generational status and duration of residence predict diabetes prevalence among Latinos: the California Men's Health Study. BMC Public Health. 2009 Oct 19; 9:392.
    View in: PubMed
    Score: 0.020
  80. Racial disparities in erectile dysfunction among participants in the California Men's Health Study. J Sex Med. 2009 Dec; 6(12):3433-9.
    View in: PubMed
    Score: 0.020
  81. Statin use and risk of colorectal cancer in a cohort of middle-aged men in the US: a prospective cohort study. Drugs. 2009 Jul 30; 69(11):1445-57.
    View in: PubMed
    Score: 0.020
  82. Access to information sources and treatment considerations among men with local stage prostate cancer. Urology. 2009 Sep; 74(3):509-15.
    View in: PubMed
    Score: 0.020
  83. Sexual function and aging in racially and ethnically diverse women. J Am Geriatr Soc. 2009 Aug; 57(8):1362-8.
    View in: PubMed
    Score: 0.020
  84. Effect of intensive glycemic control and diabetes complications on lower urinary tract symptoms in men with type 1 diabetes: Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) study. Diabetes Care. 2009 Apr; 32(4):664-70.
    View in: PubMed
    Score: 0.019
  85. Obstructive defecation in middle-aged women. Dig Dis Sci. 2008 Oct; 53(10):2702-9.
    View in: PubMed
    Score: 0.018
  86. Glycemic status and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev. 2008 Mar; 17(3):628-35.
    View in: PubMed
    Score: 0.018
  87. Effects of urinary incontinence, comorbidity and race on quality of life outcomes in women. J Urol. 2008 Feb; 179(2):651-5; discussion 655.
    View in: PubMed
    Score: 0.018
  88. Statin use and risk of prostate cancer in the California Men's Health Study cohort. Cancer Epidemiol Biomarkers Prev. 2007 Nov; 16(11):2218-25.
    View in: PubMed
    Score: 0.018
  89. Minimum incidence of primary cervical dystonia in a multiethnic health care population. Neurology. 2007 Aug 14; 69(7):676-80.
    View in: PubMed
    Score: 0.018
  90. Pooled analysis of tobacco use and risk of Parkinson disease. Arch Neurol. 2007 Jul; 64(7):990-7.
    View in: PubMed
    Score: 0.017
  91. Effect of non-steroidal anti-inflammatory medications on the risk of amyotrophic lateral sclerosis. Amyotroph Lateral Scler. 2007 Jun; 8(3):157-63.
    View in: PubMed
    Score: 0.017
  92. Symptomatic pelvic organ prolapse: prevalence and risk factors in a population-based, racially diverse cohort. Obstet Gynecol. 2007 Jun; 109(6):1396-403.
    View in: PubMed
    Score: 0.017
  93. Concordance of chart abstraction and patient recall of intrapartum variables up to 53 years later. Am J Obstet Gynecol. 2007 Mar; 196(3):233.e1-6.
    View in: PubMed
    Score: 0.017
  94. Genome-wide association study of prostate-specific antigen levels identifies novel loci independent of prostate cancer. Nat Commun. 2017 01 31; 8:14248.
    View in: PubMed
    Score: 0.017
  95. Effect of reproductive factors and postmenopausal hormone use on the risk of amyotrophic lateral sclerosis. Neuroepidemiology. 2006; 27(3):117-21.
    View in: PubMed
    Score: 0.016
  96. Fecal incontinence in females older than aged 40 years: who is at risk? Dis Colon Rectum. 2006 Jun; 49(6):841-51.
    View in: PubMed
    Score: 0.016
  97. Urinary incontinence and pelvic floor dysfunction in Asian-American women. Am J Obstet Gynecol. 2006 Nov; 195(5):1331-7.
    View in: PubMed
    Score: 0.016
  98. Sexual activity and function in middle-aged and older women. Obstet Gynecol. 2006 Apr; 107(4):755-64.
    View in: PubMed
    Score: 0.016
  99. Effect of reproductive factors and postmenopausal hormone use on the risk of Parkinson disease. Neurology. 2005 Aug 09; 65(3):383-90.
    View in: PubMed
    Score: 0.015
  100. A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences. Cancer Discov. 2015 Aug; 5(8):878-91.
    View in: PubMed
    Score: 0.015
  101. Cigarette smoking and pulmonary tuberculosis in northern California. J Epidemiol Community Health. 2015 Jun; 69(6):568-73.
    View in: PubMed
    Score: 0.015
  102. Testing for prostate and colorectal cancer: comparison of self-report and medical record audit. Prev Med. 2004 Jul; 39(1):27-35.
    View in: PubMed
    Score: 0.014
  103. Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results. J Natl Cancer Inst. 2014 Mar; 106(3):djt465.
    View in: PubMed
    Score: 0.014
  104. An absolute risk model to identify individuals at elevated risk for pancreatic cancer in the general population. PLoS One. 2013; 8(9):e72311.
    View in: PubMed
    Score: 0.013
  105. Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol. 2003 Jun 01; 157(11):1015-22.
    View in: PubMed
    Score: 0.013
  106. Initial treatment for prostate carcinoma in relation to comorbidity and symptoms. Cancer. 2002 Dec 01; 95(11):2308-15.
    View in: PubMed
    Score: 0.013
  107. Air pollution and hospital admissions for ischemic heart disease in persons with congestive heart failure or arrhythmia. Environ Health Perspect. 2002 Dec; 110(12):1247-52.
    View in: PubMed
    Score: 0.013
  108. Different slopes for different folks: socioeconomic and racial/ethnic disparities in asthma and hay fever among 173,859 U.S. men and women. Environ Health Perspect. 2002 Apr; 110 Suppl 2:211-6.
    View in: PubMed
    Score: 0.012
  109. Pelvic organ prolapse surgery in the United States, 1997. Am J Obstet Gynecol. 2002 Apr; 186(4):712-6.
    View in: PubMed
    Score: 0.012
  110. Effect of sexually transmitted infections, lifetime sexual partner count, and recreational drug use on lower urinary tract symptoms in men who have sex with men. Urology. 2012 Jan; 79(1):188-93.
    View in: PubMed
    Score: 0.012
  111. Cohort study of pioglitazone and cancer incidence in patients with diabetes. Diabetes Care. 2011 Apr; 34(4):923-9.
    View in: PubMed
    Score: 0.011
  112. Body size, age at shaving initiation, and prostate cancer in a large, multiracial cohort. Prostate. 2000 May 01; 43(2):136-43.
    View in: PubMed
    Score: 0.011
  113. The cost of health conditions in a health maintenance organization. Med Care Res Rev. 2000 Mar; 57(1):92-109.
    View in: PubMed
    Score: 0.010
  114. Medical history, body size, and cigarette smoking in relation to fatal prostate cancer. Cancer Causes Control. 2010 Jan; 21(1):117-25.
    View in: PubMed
    Score: 0.010
  115. Cause of death in men diagnosed with prostate carcinoma. Cancer. 1998 Sep 15; 83(6):1180-8.
    View in: PubMed
    Score: 0.009
  116. Race, prostate cancer survival, and membership in a large health maintenance organization. J Natl Cancer Inst. 1998 Jul 01; 90(13):986-90.
    View in: PubMed
    Score: 0.009
  117. Racial differences in treatment of early-stage prostate cancer. Urology. 2008 Jun; 71(6):1172-6.
    View in: PubMed
    Score: 0.009
  118. Evaluation of parturition and other reproductive variables as risk factors for urinary incontinence in later life. Obstet Gynecol. 1997 Dec; 90(6):983-9.
    View in: PubMed
    Score: 0.009
  119. Medically recognized urinary incontinence and risks of hospitalization, nursing home admission and mortality. Age Ageing. 1997 Sep; 26(5):367-74.
    View in: PubMed
    Score: 0.009
  120. Correlates of screening sigmoidoscopy use among men in a large nonprofit health plan. Cancer. 2007 Jul 15; 110(2):275-81.
    View in: PubMed
    Score: 0.009
  121. Screening by prostate-specific antigen and digital rectal examination in relation to prostate cancer mortality: a case-control study. Epidemiology. 2005 May; 16(3):367-76.
    View in: PubMed
    Score: 0.007
  122. Risk factors for pancreatic cancer: an exploratory study. Int J Epidemiol. 1993 Feb; 22(1):30-7.
    View in: PubMed
    Score: 0.006
  123. Thyroid hormone use and the risk of hip fracture in women > or = 65 years: a case-control study. J Womens Health (Larchmt). 2003 Jan-Feb; 12(1):27-31.
    View in: PubMed
    Score: 0.006
  124. Forced expiratory volume (1 second) and lung cancer incidence and mortality. Epidemiology. 1992 May; 3(3):253-7.
    View in: PubMed
    Score: 0.006
  125. Occupation and the occurrence of testicular cancer. Am J Ind Med. 1991; 19(3):327-37.
    View in: PubMed
    Score: 0.006

© 2024 Kaiser Permanente